GlassScriptPhysician profile
Martin H Bartels
NPI 1417949710
$6,998.39
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,005 · 2020: $1,568 · 2021: $2,204 · 2022: $1,222.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,613.33 | 2019-2022 | |
| Glaxosmithkline, LLC. | $2,008.40 | 2019-2022 | |
| Csl Behring | $352.26 | 2020-2022 | |
| Amgen INC. | $284.96 | 2022 | |
| Genzyme Corporation | $264.12 | 2019-2021 | |
| Optinose US, INC. | $243.91 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $237.19 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $171.69 | 2019-2022 | |
| Grifols USA, LLC | $144.97 | 2020-2021 | |
| Shire North American Group INC | $122.95 | 2019 | |
| Octapharma USA, INC. | $116.48 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $100.58 | 2020-2021 | |
| Pharming Healthcare, INC. | $75.46 | 2021-2022 | |
| Pfizer INC. | $75.26 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $48.22 | 2020-2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $36.11 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $23.88 | 2019 | |
| Kaleo, INC. | $22.75 | 2022 | |
| Sunovion Pharmaceuticals INC. | $22.04 | 2019 | |
| Bio Products Laboratory USA, INC. | $21.52 | 2022 | |
| Mylan Specialty L.P. | $12.31 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Martin Bartels listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.